HOCXF yields 666.67% · JNJ yields 2.13%● Live data
📍 HOCXF pulled ahead of the other in Year 1
Combined, HOCXF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HOCXF + JNJ for your $10,000?
Promotora de Hoteles Norte 19, S.A.B. de C.V. develops, operates, and manages hotels in Mexico, Costa Rica, Colombia, and Chile. The company operates hotels under the City Junior by Marriott, City Express Suites by Marriott, City Express by Marriott, City Express Plus by Marriott, and City Centro by Marriott brands. It also provides marketing, technical, and administrative; real estate development; restaurant operation and catering; and IT, server maintenance, update, and equipment rental services, as well as software platforms and applications; and dashboards for hotel managers and operating teams. In addition, the company develops Front2Go, a property management system; hires personnel or third parties for the development of civil works; and invests in hospitality industry projects. It serves business travelers. The company was formerly known as Hoteles City Express, S.A.B. de C.V. and changed its name to Promotora de Hoteles Norte 19, S.A.B. de C.V. in April 2024. Promotora de Hoteles Norte 19, S.A.B. de C.V. was incorporated in 2002 and is headquartered in Mexico City, Mexico.
Full HOCXF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.